Shanghai Pharm: purchase of Vitaco approved by Australian authorities

Summary: SIIC, Shanghai Pharm's wholly owned subsidiary, plans to purchase 60% of the shares in Australian healthcare company Vitaco for USD136.02 million (RMB938.00 million). This merger was approved by the Federal Court of Australia on 6 Dec., 2016...

Vitamins China E-News 201612

www.cnchemicals.com